Quick Answer
BioLineRx Ltd. reported Gross Profit of $950.0 thousand for the year ending 2025.
- BioLineRx Ltd. showed a decrease of -95.2% in Gross Profit from 2024 to 2025.
- This data is from BioLineRx Ltd.'s annual report (Form 10-K), filed with the SEC on March 23, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: $950.0 thousand | Fiscal year 2024: $19.68 million | Fiscal year 2023: $1.11 million | Fiscal year 2022: $0.00 | Fiscal year 2021: $0.00.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: